Pfizer's Litesse
Pfizer's specialty chemical group unveiled the FDA-approved polydextrose bulking agent family Feb. 7. Pfizer said that Litesse offers "greater versatility in formulating lower-calorie foods by providing the bulk that is lost when sugar is removed in the new 'lite' foods." In a separate announcement, Monsanto indicated that its NutraSweet subsidiary will not develop any more products using its Simplesse artificial fat used in its "Simple Pleasures" frozen dessert.
More from Archive
More from Pink Sheet
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.
In an unusual move, Tracy Beth Høeg, a special assistant to FDA Commissioner Martin Makary, is leading the continued negotiations on Novavax’s delayed COVID-19 vaccine approval.
Respondents to a Senate investigation that could re-energize 340B reform efforts said hospitals offer patient assistance programs and use 340B revenue for “capital improvement projects” and “community benefit programs,” though they do not account for specific program revenue allocations.